Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer (vol 6, pg 10604, 2015)

被引：0
|
作者：
Marin-Aguilera, Mercedes
Reig, Oscar
Lozano, Juan Jose
Jimenez, Natalia
Garcia-Recio, Susana
Erill, Nadina
Gaba, Lydia
Tagliapietra, Andrea
Ortega, Vanesa
Carrera, Gemma
Colomer, Anna
Gascon, Pedro
Mellado, Begona
机构：
来源：
ONCOTARGET | 2017年 / 8卷 / 16期
关键词：
D O I：
10.18632/oncotarget.17148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：27673 / 27673
页数：1
相关论文
共 50 条
  • [1] Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
    Marin-Aguilera, Mercedes
    Reig, Oscar
    Jose Lozano, Juan
    Jimenez, Natalia
    Garcia-Recio, Susana
    Erill, Nadina
    Gaba, Lydia
    Tagliapietra, Andrea
    Ortega, Vanesa
    Carrera, Gemma
    Colomer, Anna
    Gascon, Pedro
    Mellado, Begona
    ONCOTARGET, 2015, 6 (12) : 10604 - 10616
  • [2] MOLECULAR PROFILING OF PERIPHERAL BLOOD IS ASSOCIATED WITH CIRCULATING TUMOR CELLS (CTCS) CONTENT AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Gaba Garcia, L.
    Marin-Aguilera, M.
    Lozano, J. J.
    Tagliapietra, A.
    Ortega, V.
    Gascon, P.
    Mellado, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 300 - 300
  • [3] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
  • [4] Circulating tumor cells in metastatic castration-resistant prostate cancer
    Brian I. Rini
    Current Oncology Reports, 2009, 11 : 163 - 164
  • [5] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer
    Theil, Gerit
    Schmidt, Stefanie
    Fischer, Kersten
    Lucke, Klaus
    Fornara, Paolo
    CANCER RESEARCH, 2016, 76
  • [7] Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer
    Groen, Levi
    Kloots, Iris
    Englert, David
    Seto, Kelly
    Estafanos, Lana
    Smith, Paul
    Verhaegh, Gerald W.
    Mehra, Niven
    Schalken, Jack A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [8] Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer
    Wang, Jasmine J.
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Cook-Wiens, Galen
    Yao, Nu
    Chu, Gina C.
    Chen, Pin-Jung
    Yang, Yingying
    Yeo, Yee Hui
    Lee, Yi-Te
    Chung, Leland W.
    You, Sungyong
    Zhu, Yazhen
    Freeman, Michael R.
    Rogatko, Andre
    Yang, Ju Dong
    Tseng, Hsian-Rong
    Posadas, Edwin M.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer (vol 14, pg 6302, 2008)
    de Bono, J. S.
    Scher, H., I
    Montgomery, R. B.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1506 - 1506
  • [10] Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
    de Bono, Johann S.
    Scher, Howard I.
    Montgomery, R. Bruce
    Parker, Christopher
    Miller, M. Craig
    Tissing, Henk
    Doyle, Gerald V.
    Terstappen, Leon W. W. M.
    Pienta, Kenneth J.
    Raghavan, Derek
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6302 - 6309
12345